BioMarck Pharmaceuticals Ltd
Pharmaceutical company · Durham, North Carolina, United States
BioMarck Pharmaceuticals Ltd is a pharmaceutical company headquartered in Durham, North Carolina, United States. It has received 6 US government small-business research awards (SBIR/STTR) from health agencies, $9.5 million in total, most recently in 2019. It has reported private securities offerings to the US SEC, most recently $751,320 sold in a notice filed in 2017.
BioMarck Pharmaceuticals at a glance
What does BioMarck Pharmaceuticals do?
US government research funding
6 SBIR/STTR small-business research awards from US health agencies, $9.5 million in total (2003 to 2019). NIH funding came from the National Eye Institute.
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $751,320 sold (2017).
Frequently asked questions about BioMarck Pharmaceuticals
Where is BioMarck Pharmaceuticals headquartered?
BioMarck Pharmaceuticals Ltd is headquartered in Durham, North Carolina, United States.
What does BioMarck Pharmaceuticals do?
BioMarck Pharmaceuticals Ltd is a pharmaceutical company.
Similar companies
- Opus Genetics, Inc.Durham, North Carolina, United States
- Polarean, Inc.Durham, North Carolina, United States
- T3D Therapeutics, Inc.Durham, North Carolina, United States
- Chimerix IncDurham, North Carolina, United States
- LadeRx, LLCDurham, North Carolina, United States
- G1 Therapeutics, Inc.Durham, North Carolina, United States
- Satsuma Pharmaceuticals, Inc.Durham, North Carolina, United States
- Tellus Therapeutics, Inc.Durham, North Carolina, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences